National Health Act 1953 Amendment determination under section 85B price determinations and special patient contributions (No. PB 110 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 110 of 2009

Amendment determination under section 85B of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 85B of the National Health Act 1953.

Dated 12 November 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment — price determinations and special patient contributions

1              Commencement  

This instrument commences on 1 December 2009.

2              Amendment of PB 118 of 2008

Schedule 1 amends PB 118 of 2008.

Schedule 1        Amendments

[1]           Schedule 1, item dealing with Allopurinol in the form Tablet 100 mg

omit from the column headed “Claimed Price”:   7.55   and substitute:            8.04

[2]           Schedule 1, item dealing with Allopurinol in the form Tablet 300 mg

omit from the column headed “Claimed Price”:   5.04   and substitute:            5.83

[3]           Schedule 1, item dealing with Betamethasone in the form Cream 200 micrograms (as valerate) per g, 100 g

omit from the column headed “Claimed Price”:   10.68  and substitute:            11.08

[4]           Schedule 1, item dealing with Betamethasone in the forms Cream 500 micrograms (as valerate) per g, 15 g and Ointment 500 micrograms (as valerate) per g, 15 g

omit from the column headed “Claimed Price”:   3.44    and substitute:            3.97

[5]           Schedule 1, omit item dealing with Cefotaxime

[6]           Schedule 1, omit item dealing with Cimetidine in the form Tablet 200 mg

[7]           Schedule 1, item dealing with Digoxin in the form Tablet 62.5 micrograms

omit from the column headed “Claimed Price”:   5.14    and substitute:            5.88

[8]           Schedule 1, item dealing with Digoxin in the form Tablet 250 micrograms

omit from the column headed “Claimed Price”:   5.43    and substitute:            6.16

[9]           Schedule 1, item dealing with Glyceryl Trinitrate

omit from the column headed “Claimed Price”:   6.49    and substitute:            6.94

[10]         Schedule 1, item dealing with Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g, 30 g

omit from the column headed “Claimed Price”:   3.85    and substitute:            4.30

[11]         Schedule 1, item dealing with Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g, 50 g (Sigmacort)

omit from the column headed “Claimed Price”:   3.57    and substitute:            4.02

[12]         Schedule 1, item dealing with Hydrocortisone in the form Ointment containing hydrocortisone acetate 10 mg per g, 30 g

omit from the column headed “Claimed Price”:   3.85    and substitute:            4.30

[13]         Schedule 1, item dealing with Hydrocortisone in the form Ointment containing hydrocortisone acetate 10 mg per g, 50 g

omit from the column headed “Claimed Price”:   3.57    and substitute:            4.02

[14]         Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol

(three instances)

omit from the column headed “Claimed Price”:   20.39  and substitute:            21.88

[15]         Schedule 1, item dealing with Minocycline

omit from the column headed “Claimed Price”:   8.63    and substitute:            9.30

[16]         Schedule 1, item dealing with Omeprazole

omit from the column headed “Claimed Price”:   22.76  and substitute:            23.19

[17]         Schedule 1, item dealing with Ondansetron in the form I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL

(a) omit from the column headed “Determined Price”:    16.52  and substitute:            14.27

(b) omit from the column headed “Claimed Price”:         17.12  and substitute:            14.87

[18]         Schedule 1, item dealing with Ondansetron in the form I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL

(a) omit from the column headed “Determined Price”:    26.24  and substitute:            22.67

(b) omit from the column headed “Claimed Price”:         26.83  and substitute:            23.25

[19]         Schedule 1, item dealing with Oxazepam in the form Tablet 15 mg

omit from the column headed “Claimed Price”:   2.61    and substitute:            3.17

[20]         Schedule 1, item dealing with Oxazepam in the form Tablet 30 mg

omit from the column headed “Claimed Price”:   2.87    and substitute:            3.49

[21]         Schedule 1, omit item dealing with Potassium Chloride with Potassium Bicarbonate

[22]         Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 10 mg

(a) omit from the column headed “Determined Price”:    13.25  and substitute:            13.19

(b) omit from the column headed “Claimed Price”:         16.31  and substitute:            16.25

[23]         Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 20 mg

(a) omit from the column headed “Determined Price”:    21.05 and substitute:            20.97

(b) omit from the column headed “Claimed Price”:         24.11 and substitute:            24.04

[24]         Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 40 mg

(a) omit from the column headed “Determined Price”:    32.78  and substitute:            32.63

(b) omit from the column headed “Claimed Price”:         35.85  and substitute:            35.70

[25]         Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 80 mg

(a) omit from the column headed “Determined Price”:    50.26  and substitute:            50.08

(b) omit from the column headed “Claimed Price”:         53.33  and substitute:            53.15

[26]         Schedule 1, item dealing with Quinapril in the form Tablet 5 mg (as hydrochloride)

(a) omit from the column headed “Determined Price”:    6.75    and substitute:            6.56

(b) omit from the column headed “Claimed Price”:         7.17    and substitute:            6.98

[27]         Schedule 1, item dealing with Quinapril in the form Tablet 10 mg (as hydrochloride)

(a) omit from the column headed “Determined Price”:    9.57    and substitute:            9.34

(b) omit from the column headed “Claimed Price”:         10.15  and substitute:            9.91

[28]         Schedule 1, item dealing with Quinapril in the form Tablet 20 mg (as hydrochloride)

(a) omit from the column headed “Determined Price”:    11.84  and substitute:            11.57

(b) omit from the column headed “Claimed Price”:         12.70  and substitute:            12.44

[29]         Schedule 1, omit item dealing with Quinine

[30]         Schedule 1, item dealing with Thyroxine in the form Tablet containing 50 micrograms anhydrous thyroxine sodium

omit from the column headed “Claimed Price”:   16.45  and substitute:            16.82

[31]         Schedule 1, item dealing with Thyroxine in the form Tablet containing 75 micrograms anhydrous thyroxine sodium

omit from the column headed “Claimed Price”:   17.18  and substitute:            17.58

[32]         Schedule 1, item dealing with Thyroxine in the form Tablet containing 100 micrograms anhydrous thyroxine sodium

omit from the column headed “Claimed Price”:   17.01  and substitute:            17.38

[33]         Schedule 1, item dealing with Thyroxine in the form Tablet containing 200 micrograms anhydrous thyroxine sodium

omit from the column headed “Claimed Price”:   19.74  and substitute:            20.10

[34]         Schedule 1, item dealing with Trandolapril in the form Capsule 500 micrograms

(a) omit from the column headed “Determined Price”:    3.37    and substitute:            2.68

(b) omit from the column headed “Claimed Price”:         4.74    and substitute:            4.30

[35]         Schedule 1, item dealing with Trandolapril in the form Capsule 1 mg

(a) omit from the column headed “Determined Price”:    7.52    and substitute:            6.85

(b) omit from the column headed “Claimed Price”:         8.89    and substitute:            8.48

[36]         Schedule 1, item dealing with Trandolapril in the form Capsule 2 mg

(a) omit from the column headed “Determined Price”:    8.53    and substitute:            8.24

(b) omit from the column headed “Claimed Price”:         9.90    and substitute:            9.88

[37]         Schedule 1, item dealing with Trandolapril in the form Capsule 4 mg

(a) omit from the column headed “Determined Price”:    15.86  and substitute:            15.37

(b) omit from the column headed “Claimed Price”:         17.23  and substitute:            17.00

[38]         Schedule 1, item dealing with Triamcinolone in the forms Cream containing triamcinolone acetonide 200 micrograms per g, 100 g and Ointment containing triamcinolone acetonide 200 micrograms per g,

100 g

omit from the column headed “Claimed Price”:   5.01    and substitute:            5.12

[39]         Schedule 1, item dealing with Trimethoprim

omit from the column headed “Claimed Price”:   2.69    and substitute:            3.14

[40]         Schedule 1, item dealing with Trimethoprim with Sulfamethoxazole in the form Tablet 160 mg-800 mg

omit from the column headed “Claimed Price”:   3.54    and substitute:            3.92

[41]         Schedule 1, item dealing with Trimethoprim with Sulfamethoxazole in the form Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL

omit from the column headed “Claimed Price”:   3.56    and substitute:            3.94